Botanix up on study results

29/01/2018 - 15:20

Bookmark

Upgrade your subscription to use this feature.

Shares in medical dermatology company Botanix Pharmaceuticals, led by Perth-based chairman Graham Griffiths and executive director Matt Callahan, have jumped more than 20 per cent today after the company announced successful results from an acne patient study.

This article is only available to our paid subscribers.

To read this article and get full access to every insight Business News offers, subscribe today.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options